← FDA Drug Approvals (Drugs@FDA)

SURFAXIN

NDA · New Drug Application · Sponsor: LEES PHARM HK · Approved 2012-03-06

Drug application

FDA Application #

NDA021746

Application type

New Drug Application

Brand name

SURFAXIN

Generic name

Lucinactant

Active ingredients

LUCINACTANT

Dosage form

SUSPENSION

Route

INTRATRACHEAL

Marketing status

Discontinued

Sponsor

LEES PHARM HK

First approval

2012-03-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown